Johnson City, tenn.,, July 15, 2025 / Prnewswire / – LabConnect is pleased to announce the appointment of Mitch Blumenfeld As a financial director, efficient August 4, 2025. Mitch joins Labconnect with experienced experience as a financial director for high -growth companies in several sectors, including pharmaceutical services, wholesale pharmaceutical distribution and diversified manufacturing and consumption products. With more than three decades of experience in leadership, Mitchell brings a vast expertise in the financial management of companies and strategic development.
Before joining LabConnect, Mr. Blumenfeld was a financial director of Network Partners Group, a world consulting company in life sciences and medical systems providing quality services, regulatory business, project management, packaging engineering and labeling. Previously, Mitch has been a financial director of Signeur Health, a world leader in the software and services market supporting clinical research and the PCI Pharma Services, a development and manufacturing organization of contracts. Additional additional leadership roles include amerisourcebergen Corporation and several commercial units within General Electric. Mr. Blumenfeld holds a master’s degree in computer science and Virginia Tech and a baccalaureate of science and engineering from Bucknell University.
“I am delighted to welcome Mitch to Labconnect and our management team,” said Wes Wheeler, Managing Director of Labconnect. “I am convinced that his leadership and expertise will play a vital role in the conduct of profitable growth at LabConnect, the realization of operational excellence through the company and to advance our capital allowance priorities.”
As LabConnect financial director, Mitch will lead the global financial organization of the company and will be responsible for financing businesses, accounting, treasury, financial planning and analysis, tax and investors.
“I am delighted to join Labconnect at such a pivotal time,” said Blumenfeld. “The company redefines central global services, and I can’t wait to help shape this trip.”
About LabConnect
LabConnect is the partner of the most agile central laboratory solutions in the world, providing technology -oriented support services, personalized, orchestrated and scalable for clinical trials of all sizes and complexity. With more than 20 years of experience and more than 2,000 clinical studies in 93 countries, Labconnect is the trusted partner of biotechnology, pharmaceutical and clinical research organizations.
With modern operations and strategic alliances with advanced laboratories, LabConnect is only positioned to give access to the latest innovations and automation. LABCONNECT offers an exceptional service with a complete suite of central laboratory solutions, including personalized laboratory kits, advanced monitoring of samples and integrated logistics, processing of global standardized samples, a peak test menu of more than 20,000 validated tests, global care for radiopharmaceuticals and a new generation bioreposory.
LabConnect Scientific experts support preclinical and clinical studies with scientific project management, bioanalytic and bioscimile management, biomarker strategy and logistical solutions. LabConnect excels in data management, incorporating complex data sets from various sources in a coherent and coherent and ready -made data set.
Follow LabConnect on Linkedin
Learn more about www.labconnect.com
Logo – https://mma.prnewswire.com/media/2611513/labcconnect_logo.jpg
Show the original content:https://www.prnewswire.com/apac/news-releases/labConnect-appointts-mitchell-blumenfeld-as-chief financial-offiter-302504581.html
LabConnect Source
